PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) was downgraded by Wells Fargo & Company from an “overweight” rating to an “equal weight” rating in a report released on Wednesday. Get PROCEPT BioRobotics alerts:Read Our Latest Analysis on PRCTPROCEPT BioRobotics Price PerformanceShares of NASDAQ:PRCT opened at $18.28 on Wednesday. PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. As a group, equities analysts forecast that PROCEPT BioRobotics will post -1.53 earnings per share for the current fiscal year. Read MoreReceive News & Ratings for PROCEPT BioRobotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PROCEPT BioRobotics and related companies with MarketBeat.com's FREE daily email newsletter.